Abstract:Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): European Society of Cardiology Basic Research Fellowship. Dutch Heart Foundation Dekker Grant Background Inherited arrhythmia syndromes are a leading cause of sudden cardiac death in young and otherwise healthy patients. They are often caused by mutations in genes that encode ion channels or transporters, leading to conditions such as Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). CPVT is caused by mutations in RYR2 (encoding ryanodine receptor 2, RyR2). In arrhythmia research, investigation into the effects of these mutations have exclusively been performed in cardiac cells. However, RyR2 is also present in neuronal tissue, including intracardiac neurons [1] (which modulate cardiac function). Moreover, patients often present with clinical signs of autonomic nervous system (ANS) dysfunction, and treatment strategies frequently target the ANS. Aim Our novel research line aims to investigate the neuronal phenotype induced by RyR2 mutations, using a CPVT mouse model to assess functional alterations as well as broader autonomic remodelling. Results Using immunocytochemistry, we reveal for the first time that RyR2 is also expressed in mouse stellate ganglia (crucial autonomic modulators of cardiac function). Through analysis of published RNA sequencing datasets, we find that RYR2 is more abundantly expressed in both stellate ganglion and intracardiac neurons than characteristic neuronal markers such as CHAT, SYN1 and SCN8A [2,3]. Functional patch clamp investigation of isolated stellate ganglion neurons have revealed two distinct populations based on their patterns of action potential (AP) firing, identifying both phasic-firing and tonic-firing type neurons. Investigation of an established CPVT mouse model (RyR2-R2474S) has thus far not revealed any differences in the AP firing frequency of isolated stellate ganglion neurons during sustained depolarising stimuli of various amplitudes. Assessment of calcium homeostasis and neurotransmitter release is currently ongoing. We have furthermore investigated broader autonomic remodelling using immunohistochemistry in mouse heart cryosections. Neuronal innervation density was assessed by staining 10 μm sections of mid-ventricular myocardium for the sympathetic neuron marker tyrosine hydroxylase (TH). Quantification of the TH-positive area revealed a significant increase in the percentage of sympathetic neuronal innervation in ventricular tissue of CPVT mice (5.7% wild-type vs 7.2% RyR2-R2474S, p=0.0253, N=6). Conclusions The neurons that modulate heart function (stellate ganglion and intracardiac neurons) abundantly express RyR2. The RyR2-R2474S mutation leads to significant sympathetic hyper-innervation of ventricular myocardium, which may have important consequences for neurotransmitter release and hence cardiac (electrical) function and arrhythmogenesis.

Absence of Rgs5 Influences the Spatial and Temporal Fluctuation of Cardiac Repolarization in Mice

Absence of Rgs5 Prolongs Cardiac Repolarization and Predisposes to Ventricular Tachyarrhythmia in Mice

Abstract 188: Atrial Tachyarrhythmia in Rgs5-Null Mice

Atrial Tachyarrhythmia in Rgs5-Null Mice

Potential Role Of Regulator Of G-Protein Signaling 5 In The Protection Of Vagal-Related Bradycardia And Atrial Tachyarrhythmia

Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias and disrupts the fine-tuning of Gi/o signaling

LRP5 Controls Cardiac QT Interval by Modulating the Metabolic Homeostasis of L-type Calcium Channel.

Regulator of G-protein signalling 5 deficiency impairs ventricular remodelling after myocardial infarction by promoting NF-κB and MAPK signalling in mice.

Regulator of G Protein Signaling 5 Protects Against Cardiac Hypertrophy and Fibrosis During Biomechanical Stress of Pressure Overload

Atrial Arrhythmogenesis in Wild-Type and Scn5a+/Δ Murine Hearts Modelling LQT3 Syndrome

The RyR2-P2328S Mutation Downregulates Nav1.5 Producing Arrhythmic Substrate in Murine Ventricles

Arrhythmic Substrate, Slowed Propagation and Increased Dispersion in Conduction Direction in the Right Ventricular Outflow Tract of Murine Scn5a+/- Hearts

Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.

Β Adrenergic Receptor-Mediated Atrial Specific Up-Regulation of RGS5

Regulator of G-protein Signaling 5 Protects Cardiomyocytes Against Apoptosis During in Vitro Cardiac Ischemia-Reperfusion in Mice by Inhibiting Both JNK1/2 and P38 Signaling Pathways.

Age-Dependent Electrical Remodelling In R33q Catecholaminergic Ventricular Tachycardia Knock-In Mouse Model

Nonlinear Analysis of Beat-To-Beat Variability of Action Potential Time Series Data Identifies Dynamic Reentrant Substrates in a Hypokalaemic Mouse Model of Acquired Long QT Syndrome

Splicing Factor Srsf5 Deletion Disrupts Alternative Splicing and Causes Noncompaction of Ventricular Myocardium

Dose-Dependent Arrhythmia and Cardiac Dysfunction in Restrictive Cardiomyopathy Mice Due to Troponin Mutations

Molecular basis of ventricular arrhythmogenicity in a Pgc-1α deficient murine model

Ventricular hyperinnervation in a mouse model of catecholaminergic polymorphic ventricular tachycardia